CEVIMELINE
CEVIMELINE HYDROCHLORIDE
- Strength
- 30 mg/1
- Form
- Capsule
- Class
- Cholinergic Receptor Agonist
Bionpharma Inc
Not stocked by us — reference only
Listed by Aurobindo Pharma Limited
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Cholinergic Receptor Agonist |
| Approval route | ANDA — approved generic |
| NDC code | 59651-422 |
| FDA application | ANDA215056 |
| RxNorm concept | 309140 |
| Package sizes listed | 2 |
| Marketed since | April 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
CEVIMELINE HYDROCHLORIDE
Bionpharma Inc
Not stocked by us — reference only
Sun Pharmaceutical Industries, Inc.
Not stocked by us — reference only
Lupin Pharmaceuticals,Inc.
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Cosette Pharmaceuticals, Inc.
Not stocked by us — reference only
ASCLEMED USA INC.
Not stocked by us — reference only
Bryant Ranch Prepack
Not stocked by us — reference only
Zydus Lifesciences Limited
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.